Shareholders say directors of NRG Energy unreasonably rejected a $6.2 billion buyout offer from Exelon - 0.485 Exelon shares for each NRG share - in Delaware Chancery Court.
Shareholders sued Omrix Pharmaceuticals in New York County Court, seeking to enjoin its acquisition by Johnson & Johnson.
Directors of Transmeta Corp. unfairly capped the stock price in Novafora's $255 million buyout offer, shareholders say in Santa Clara County Court, Calif.
Reserve Management Co. inflated the price of its Reserve Short-Term Trust and Reserve Yield Plus mutual funds through false and misleading statements, shareholders claim in Manhattan Federal Court.
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.
Additional Reads
-
Do you know what’s really in your ESG fund? January 17, 2023 -
Elon Musk rebuffed in bid to move Tesla tweet trial to Texas January 13, 2023